Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Discover which cashback cards are fee-free and how they can benefit your finances. Make informed choices!
26,758 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
LifeStance Health Group stunned the market with a beat-and-raise quarter, sending its stock up roughly 20%. This deep...
A niche AI hardware stock is drawing investors as hyperscale data centers surge. Analysts say this stock could easies...
Dell Technologies rides a booming AI infrastructure cycle into 2027, with a record AI backlog and ambitious revenue t...
Investors watching ecarx (ecx) 2026 earnings want clarity on how software, hardware, and services come together in th...
Pony AI's Q1 2026 earnings transcript is a pivotal moment for investors. This article breaks down the key numbers, th...
As Autohome reports Q1 2026 earnings, investors get a clear read on user momentum, ad revenue, and margin discipline....
A renewed wave of interest in AI hardware helped propel Intel shares higher in May. This article digs into the driver...
May brought a sharp rally for Tower Semiconductor as demand surged and orders extended into 2028. This analysis break...
June brings a pivotal AI stock showdown between AMD and Nvidia. This guide breaks down how to evaluate which offers b...
Rivian shocks investors by cutting jobs shortly after starting to deliver the R2. This move raises questions about ho...